Evidence map›Paper›PMID 35752633›Full record

ArticleNature communications2022

Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.

Joel O Wertheim, Jade C Wang, Mindy Leelawong, Darren P Martin, Jennifer L Havens, Moinuddin A Chowdhury, Jonathan E Pekar, Helly Amin, Anthony Arroyo, Gordon A Awandare and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Adaptive Evolution of the Spike Protein in Coronaviruses.Molecular biology and evolution · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Joel O Wertheim *Department of Medicine, University of California San Diego, La Jolla, CA, USA. jwertheim@health.ucsd.edu.ORCID 0000-0003-4882-5856
Jade C Wang *New York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA. jwang7@health.nyc.gov.ORCID 0000-0002-8855-0925
Mindy LeelawongNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.ORCID 0000-0002-3702-2938
Darren P MartinInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Jennifer L HavensBioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0003-3095-5900
Moinuddin A ChowdhuryNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Jonathan E PekarBioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, CA, USA.
Helly AminNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Anthony ArroyoNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.ORCID 0000-0002-7691-7638
Gordon A AwandareWest African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.ORCID 0000-0002-8793-3641
Hoi Yan ChowNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Edimarlyn GonzalezNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Elizabeth LuomaBureau of the Communicable Diseases, New York City Department of Health and Mental Hygiene, Long Island City, NY, USA.
Collins M Morang'aWest African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
Anton NekrutenkoDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, State College, PA, USA.
Stephen D ShankDepartment of Biology, Temple University, Philadelphia, PA, USA.
Stefan SilverNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Peter K QuashieWest African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.ORCID 0000-0003-4114-5460
Jennifer L RakemanNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Victoria RuizNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Lucia V TorianNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.
Tetyana I VasylyevaDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.
Sergei L Kosakovsky PondDepartment of Biology, Temple University, Philadelphia, PA, USA.ORCID 0000-0003-4817-4029
Scott HughesNew York City Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York, NY, USA.

Funding

Turning big data analysis infrastructure for HIV researchR01AI134384 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI NEKRUTENKO, ANTON, POND, SERGEI L KOSAKOVSKY · 2017 to 2021
$4.2M
Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV PreventionR01AI136056 · NIAID · UNIVERSITY OF CHICAGO · PI BENBOW, NANETTE DIOR, D'AQUILA, RICHARD · 2018 to 2022
$4.0M
Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York CityR01AI135992 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERTHEIM, JOEL OKRENT · 2018 to 2022
$3.6M
Medical Research Council MR/P028071/1NIAID NIH HHS R01 AI134384NIAID NIH HHS R01 AI135992NIAID NIH HHS R01 AI136056Wellcome TrustWellcome Trust 222574/Z/21/Z
6 · The paper itself

Abstract

Recombination is an evolutionary process by which many pathogens generate diversity and acquire novel functions. Although a common occurrence during coronavirus replication, detection of recombination is only feasible when genetically distinct viruses contemporaneously infect the same host. Here, we identify an instance of SARS-CoV-2 superinfection, whereby an individual was infected with two distinct viral variants: Alpha (B.1.1.7) and Epsilon (B.1.429). This superinfection was first noted when an Alpha genome sequence failed to exhibit the classic S gene target failure behavior used to track this variant. Full genome sequencing from four independent extracts reveals that Alpha variant alleles comprise around 75% of the genomes, whereas the Epsilon variant alleles comprise around 20% of the sample. Further investigation reveals the presence of numerous recombinant haplotypes spanning the genome, specifically in the spike, nucleocapsid, and ORF 8 coding regions. These findings support the potential for recombination to reshape SARS-CoV-2 genetic diversity.

Indexed as

COVID-19SuperinfectionGenome, ViralHumansNew York CityRecombination, GeneticSARS-CoV-2Spike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35752633
PMCPMC9233664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.